In its weekly summary, U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) noted, it had received 22 reports of rare brain blood clots and 8 reports of other blood clotting events out of a total of 18.1 million doses of the AstraZeneca vaccine administered as of March 24.
